Tranexamic Acid in Traumatic Brain Injury: CRASH-3 Trial

This presentation explores the CRASH-3 Trial, emphasizing its significance in traumatic brain injury (TBI) management. It reviews tranexamic acid's mechanisms, highlighting its role in bleeding control and clot stabilization. The methodology section provides insight into study design, patient demographics, and evaluation metrics. Key outcomes demonstrate tranexamic acid's effectiveness in reducing mortality, supported by statistical analysis and implications for clinical practice. Finally,...